risque (1) traitement (1) association (1) pathologie (1) modèle (1) dose (1) maladie (1) âge (1) adulte (1) taux (1) Development (1) Control (1) Cases (1) IgA glomerulonephritis (1) Vaccination (1) Swiss (1) Social groups (1) Risk (1) RNA (1) Population (1) Patients (1) Pathology (1) Messenger RNA (1) Human beings (1) Kidneys--Diseases (1) Holy Cross (1) Glomerulonephritis (1) Example (1) Design (1) Confidence (1)